Has Frank Schwab, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,144,207 in general payments to Frank Schwab, MD across 449 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Schwab, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Schwab, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Schwab, MD

Orthopaedic Surgery of the Spine · New York, NYNPI 1811077878

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $4,165,506 of the $5,144,207 with a category attached, or 81.0%. 18 manufacturers reported payments, led by Stryker at 27.0% of the total. Among orthopaedic surgery of the spine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,144,207in general payments, 2019–2025

Across 449 payments — averaging $11,457 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$1.4M
Highridge Medical LLC$689K
MML US, Inc.$644K
Medtronic$636K
Zimmer Biomet$588K
Zimvie Inc.$558K
plus $638K from 12 others

$23,750in research payments, 2019–2025

Across 4 payments — averaging $5937.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

MML US, Inc.$20K
Medtronic$4K

What the payments were for

Royalty or licence$4,165,50681%
Consulting fees$681,02013%
Speaking & faculty fees$168,9153%
Travel & lodging$117,5662%
Food & beverage$11,1010%
Education$990%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	56	$1,390,244
Highridge Medical LLC	47	$688,947
MML US, Inc.	104	$644,263
Medtronic(2 entities)	45	$635,802
Zimmer Biomet	62	$588,357
Zimvie Inc.	30	$558,460
Alphatec Spine, Inc	34	$447,500
Globus Medical(2 entities)	50	$148,770
Medicrea USA, Corp.	8	$40,684
Suvon Surgical LLC	2	$498
Johnson & Johnson	2	$284
4web, Inc.	1	$140
Cerapedics Inc.	1	$99
Carlsmed, Inc.	1	$49
Integrity Implants Inc.	2	$48
Pinnacle Transplant Technologies, LLC	1	$28
Arthrex	1	$24
Orthofix Medical, Inc.	2	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,144,207 in reported general payments places this provider in the 95th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024

$284,821

Medicare patients

189

Services billed

895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery of the spine in New York

Han KimNew York$3.9M
Todd AlbertNew York$2.7M
Jeffrey SpivakNew York$1.3M
Aaron BucklandNew York$1M
Sheeraz QureshiNew York$828K
Jeffrey GoldsteinNew York$765K
Fabien BitanNew York$624K
Oheneba Boachie-AdjeiNew York$313K
Harvinder SandhuNew York$266K
Federico GirardiNew York$144K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →